INBX Stock Analysis: Buy, Sell, or Hold?
INBX - Inhibrx Biosciences, Inc. Common Stock
$92.17
-0.84 (-0.91%)
▼
5d:
-5.12%
30d:
+3.01%
90d:
+22.45%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 12, 2026
29d
Get Alerted When INBX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called INBX this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: INBX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: INBX is currently trading at $92.17, which is considered slightly low relative to its 30-day fair value range of $90.49 to $97.49.
Technical Outlook: Technically, INBX is in a uptrend. Immediate support is located at $88.77, while resistance sits at $106.40.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (8th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $277.50 (+201.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INBX is in a uptrend. Immediate support is located at $88.77, while resistance sits at $106.40.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (8th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $277.50 (+201.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$90.49 -
$97.49
Company Quality Score
56/100
(HOLD)
Options IV Signal
8th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
86.2%
Protect Your Profits
Holding INBX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 8th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 201.1% below Wall St target ($277.50)
- CAUTION: Recommendation downgraded due to -5.1% 5-day decline
Trading Range Analysis
30-Day Trading Range
$90.49 -
$97.49
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$13.21
(14.3%)
Support & Resistance Levels
Support Level
$88.77
Resistance Level
$106.40
Current Trend
Uptrend
Technical data as of
Jul 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.63
Wall Street Target
$277.50
(+201.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: July 13, 2026 6:53 PM ET
Data refreshes hourly during market hours. Next update: 7:53 PM
Data refreshes hourly during market hours. Next update: 7:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INBX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$413 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$822 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 54 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
Advanced INBX Option Strategies
Professional options setups generated by AI based on today's INBX price and gamma walls.
